Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: Combinational approach for enhanced differentiation

Cancer Science

Volumn 100, Issue 9, 2009, Pages 1740-1747

  Shah, Navjot ^a   Kataria, Hardeep ^b   Kaul, Sunil C ^a   Ishii, Tetsuro ^a   Kaur, Gurcharan ^b   Wadhwa, Renu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b GURU NANAK DEV UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 RHAMNOPYRANOSYL(1 4) GLUCOPYRANOSYL 12 DIACETOXY 20 HYDROXYWITHA 5,24 DIENOLIDE; 3-RHAMNOPYRANOSYL(1-4)-GLUCOPYRANOSYL-12-DIACETOXY-20-HYDROXYWITHA-5,24-DIENOLIDE; DRUG DERIVATIVE; ERGOSTEROL; PLANT EXTRACT; WITHAFERIN A;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; PHYTOTHERAPY; PLANT LEAF; TUMOR CELL CULTURE; WESTERN BLOTTING; WITHANIA; WITHANIA SOMNIFERA;

BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; ERGOSTEROL; GLIOBLASTOMA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; TUMOR CELLS, CULTURED; WITHANIA;

EID: 70149089441     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01236.x     Document Type: Article

References (60)

1. Chopra RN. A review of work on Indian Medicinal plants. In Pharmacopoeia of India Indian Council of Medical Research. Cambridge Printing Works, Kashmere Gate, New Delhi, 1955.
2. Agarwal R, Diwanay S, Patki P, Patwardhan B. Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 1999; 67: 27-35.
3. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000; 5: 334-46.
4. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000; 71: 23-43.
5. Tohda C, Kuboyama T, Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport 2000; 11: 1981-5.
6. Davis L, Kuttan G. Effect of Withania somnifera on cell mediated immune responses in mice. J Exp Clin Cancer Res 2002; 21: 585-90.
7. Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 2005; 144: 961-71.
8. Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 2003; 75: 547-55.
9. Gupta SK, Dua A, Vohra BP. Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metabol Drug Interact 2003; 19: 211-22.
10. Singh B, Chandan BK, Gupta DK. Adaptogenic activity of a novel withanolide-free aqueous fraction from the roots of Withania somnifera Dun.(Part II).Phytother Res 2003;17: 531-6
11. Widodo N, Kaur K, Shrestha BG et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res 2007; 13: 2298-306.
12. Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R. Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Lett 2008; 262: 37-47.
13. Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res 2001; 15: 524-8.
14. Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta (25-35)-induced neurodegeneration. Eur J Neurosci 2006; 23: 1417-26.
15. Rani G, Kaur K, Wadhwa R, Kaul SC, Nagpal A. Evaluation of the antigenotoxicity of leaf extract of Ashwagandha. Food Chem Toxicol 2005; 43: 95-8.
16. Kaur K, Rani G, Widodo N et al. Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chem Toxicol 2004; 42: 2015-20.
17. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203-10.
18. Wadhwa R, Kaul SC, Mitsui Y, Sugimoto Y. Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. Exp Cell Res 1993; 207: 442-8.
19. Kanno H, Shinonaga M, Kuwabara T, Umeda M. [Growth factors produced by rat glioma cells: activities of transforming growth factors]. No To Shinkei 1989 ;41:905-9.
20. Wadhwa R, Sugihara T, Yoshida A et al. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res 2000; 60: 6818-21.
21. Michishita E, Nakabayashi K, Suzuki T et al. 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. J Biochem 1999; 126: 1052-9.
22. Deocaris CC, Widodo N, Shrestha BG et al. Mortalin sensitizes human cancer cells to MKT-077-induced senescence. Cancer Lett 2007; 252: 259-69.
23. Wadhwa R, Taira K, Kaul SC. Mortalin: a potential candidate for biotechnology and biomedicine. Histol Histopathol 2002; 17: 1173-7.
24. Wadhwa R, Colgin L, Yaguchi T, Taira K, Reddel RR, Kaul SC. Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo. Cancer Res 2002; 62: 4434-8.
25. Ohtsuka R, Abe Y, Fujii T et al. Mortalin is a novel mediator of erythropoietin signaling. Eur J Haematol 2007; 79: 114-25.
26. Malik F, Kumar A, Bhushan S et al. Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. Eur J Cancer 2009; 45: 1494-509.
27. Malik F, Kumar A, Bhushan S et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 2007; 12: 2115-33.
28. Aalinkeel R, Hu Z, Nair BB et al. Genomic analysis highlights the role of the JAK-STAT signaling in the anti-proliferative effects of dietary flavonoid 'Ashwagandha' in prostate cancer cells. Evid Based Complement Alternat Med 2008.
29. Diwanay S, Chitre D, Patwardhan B. Immunoprotection by botanical drugs in cancer chemotherapy. J Ethnopharmacol 2004; 90: 49-55.
30. Christina AJ, Joseph DG, Packialakshmi M et al. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma. J Ethnopharmacol 2004; 93: 359-61.
31. Kuttan G. Use of Withania somnifera Dunal as an adjuvant during radiation therapy. Indian J Exp Biol 1996; 34: 854-6.
32. Leyon PV, Kuttan G. Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother Res 2004; 18: 118-22.
33. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB, Becker LE. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res 1994; 54: 3267-72.
34. Kokunai T, Izawa I, Tamaki N. Overexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line. Int J Cancer 1998; 75: 643-8.
35. Das A, Banik NL, Ray SK. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res 2008; 1227: 207-15.
36. Nakabayashi K, Ogata T, Fujii M et al. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp Cell Res 1997; 235: 345-53.
37. Bertram MJ, Berube NG, Hang-Swanson X et al. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 1999; 19: 1479-85.
38. Fujii M, Ide T, Wadhwa R, Tahara H et al. Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts. Oncogene 1995; 11: 627-34.
39. Walsh FS, Meiri K, Doherty P. Cell signalling and CAM-mediated neurite outgrowth. Soc Gen Physiol Ser 1997; 52: 221-6.
40. Ditlevsen DK, Povlsen GK, Berezin V, Bock E. NCAM-induced intracellular signaling revisited. J Neurosci Res 2008; 86: 727-43.
41. Suzuki T, Izumoto S, Fujimoto Y, Maruno M, Ito Y, Yoshimine T. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion. J Clin Pathol 2005; 58: 166-71.
42. Amoureux MC, Cunningham BA, Edelman GM, Crossin KL. N-CAM binding inhibits the proliferation of hippocampal progenitor cells and promotes their differentiation to a neuronal phenotype. J Neurosci 2000; 20: 3631-40.
43. Krushel LA, Tai MH, Cunningham BA, Edelman GM, Crossin KL. Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci USA 1998; 95: 2592-6.
44. Kim JH, Lee JH, Park JY et al. Retrovirally transduced NCAM140 facilitates neuronal fate choice of hippocampal progenitor cells. J Neurochem 2005; 94: 417-24.
45. Prag S, Lepekhin EA, Kolkova K et al. NCAM regulates cell motility. J Cell Sci 2002; 115: 283-92.
46. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R. Elevated levels of Mr 92 000 type IV collagenase in human brain tumors. Cancer Res 1993; 53: 2208-11.
47. Edvardsen K, Brunne N, Spang-Thomsen M, Walsh FS, Bock E. Migratory, invasive and metastatic capacity of NCAM transfected rat glioma cells. Int J Dev Neurosci 1993; 11: 681-90.
48. Andersson AM, Moran N, Gaardsvoll H et al. Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells. Int J Cancer
49. Hsu WM, Lee H, Juan HF et al. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis. Clin Cancer Res 2008; 14: 6237-45.
50. Westarp ME, Westarp MP, Grundl W, Biesalski H, Kornhuber HH. Improving medical approaches to primary CNS malignancies: retinoid therapy and more. Med Hypotheses 1993; 41: 267-76.
51. Haque A, Banik NL, Ray SK. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res 2007; 32: 2203-9.
52. Zhang R, Banik NL, Ray SK. Combination of all-trans retinoic acid and interferon-gamma upregulated p27 (kip1) and downregulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer Chemother Pharmacol 2008; 62: 407-16.
53. Das A, Banik NL, Ray SK. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol 2008; 87: 9-22.
54. Karmakar S, Banik NL, Ray SK. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 2008; 112: 596-607.
55. Sharif TR, Sharif MA. High throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells. Int J Oncol 1999; 14: 327-35.
56. Schmidt F, Groscurth P, Dichgans J, Weller M. Human malignant glioma cell lines are refractory to retinoic acid-mediated differentiation and sensitization to apoptosis. Cell Physiol Biochem 2000; 10: 159-68.
57. Nordenberg J, Fenig E, Landau M, Weizman R, Weizman A. Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol 1999; 58: 1229-36.
58. Hai J, Lin Q, Lu Y, Yi J, Zhang H. Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells. Neurol Res 2008; 30: 99-105.
59. Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc Natl Acad Sci USA 2007; 104: 13 438-43.
60. Hai J, Lin Q, Lu Y. Phosphatidylinositol 3-kinase activity is required for the induction of differentiation in C6 glioma cells by panaxydol. J Clin Neurosci